Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy

ClinicalTrials.gov ID: NCT00004583

Public ClinicalTrials.gov record NCT00004583. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 2:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Phase III Study of ABT-378/Ritonavir Plus Stavudine and Lamivudine vs Nelfinavir Plus Stavudine and Lamivudine in Antiretroviral Naive HIV-Infected Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to see how safe a new protease inhibitor (PI) is and how well it fights HIV infection. A PI is a drug that stops HIV from using healthy cells to make more virus. This study will compare the new PI combination of ABT-378 plus ritonavir (RTV) with another PI, nelfinavir (NFV). Earlier studies suggest ABT-378/RTV will be just as good as and perhaps better than NFV at fighting HIV infection.

Study identification

NCT ID
NCT00004583
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
660 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 1999 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Feb 20, 2009

Started 1999

United States locations

U.S. sites
42
U.S. states
24
U.S. cities
34
Facility City State ZIP Site status
Pacific Oaks Med Group Beverly Hills California 90211 —
Orange County Ctr for Special Immunology Fountain Valley California 92708 —
AIDS Healthcare Foundation Los Angeles California 900276069 —
Tower ID Med Associates Los Angeles California 90048 —
UCLA CARE Ctr Los Angeles California 90095 —
San Francisco Veterans Administration Med Ctr San Francisco California 94121 —
Harbor - UCLA Med Ctr Torrance California 90502 —
Yale Univ / AIDS Clinical Trials Unit New Haven Connecticut 06510 —
Steinhart Medical Associates Miami Florida 33133 —
Univ of Miami School of Medicine Miami Florida 33136 —
Infectious Disease Research Institute Tampa Florida 33614 —
AIDS Research Consortium of Atlanta Atlanta Georgia 30308 —
Emory Univ Atlanta Georgia 30308 —
AIDS Research Alliance - Chicago Chicago Illinois 60657 —
Division of Inf Diseases/ Indiana Univ Hosp Indianapolis Indiana 46202 —
Univ of Kansas School of Medicine Wichita Kansas 67214 —
Tulane Univ Med School New Orleans Louisiana 70112 —
Johns Hopkins Hosp Baltimore Maryland 21205 —
Boston Med Ctr Boston Massachusetts 02118 —
Community Research Initiative of New England Brookline Massachusetts 02445 —
Univ of Michigan Hospitals and Health Ctrs Ann Arbor Michigan 481090378 —
Abbott Northwestern Hosp Minneapolis Minnesota 55407 —
East Orange Veterans Administration Med Ctr East Orange New Jersey 07018 —
Beth Israel Med Ctr New York New York 10003 —
Cornell Clinical Trials Unit - Chelsea Clinic New York New York 10011 —
Howard Grossman New York New York 10011 —
SUNY at Stony Brook / Div of Infectious Disease Stony Brook New York 117948153 —
Duke Univ Med Ctr / Infectious Disease Clinic Durham North Carolina 27710 —
Holmes Hosp / Univ of Cincinnati Med Ctr Cincinnati Ohio 452670405 —
Associates in Med and Mental Health Tulsa Oklahoma 74114 —
Oregon Health Sciences Univ Portland Oregon 972109951 —
Philadelphia FIGHT Philadelphia Pennsylvania 19107 —
Stephen Hauptman Philadelphia Pennsylvania 19107 —
The Miriam Hosp Providence Rhode Island 02906 —
Vanderbilt Univ Med Ctr Nashville Tennessee 37203 —
Central Texas Med Foundation Austin Texas 78751 —
Oaklawn Physicians Group Dallas Texas 75219 —
Univ of Texas Southwestern Med Ctr Dallas Texas 75235 —
Joseph C Gathe Houston Texas 77004 —
Infectious Disease Physicians Inc Annandale Virginia 22203 —
Univ of Virginia Health Sciences Ctr Charlottesville Virginia 22908 —
Univ of Wisconsin Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00004583, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2009 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00004583 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →